In search of future blockbusters, Big Pharma turns to psychedelics
Eli Lilly's acquisition of AtaiBeckley last month signals that major drugmakers increasingly view psychedelics as a promising source of future psychiatric medicines and new patent-protected drug franchises.Eli Lilly's announcement last month...To view the full article, register now.
Already a subscriber? Click here to view full article